A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants
Clinical trial NCT02629289 · COMPLETED
Trial details
- NCT number
- NCT02629289
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-06-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.